The mid-stage disappointment in Alzheimer’s disease delivers another blow to Neuphoria Therapeutics, which in November last year was forced to launch a strategic business review after a Phase 3 trial ...

Two-dimensional (2D) perovskites are increasingly recognized as promising candidate materials for the next generation of ...

Jul 2, 2026--United Therapeutics Corporation (Nasdaq: UTHR ) announced today it has acquired Thymmune Therapeut ...

A Seattle-based gastroenterologist shares the three types of foods known to create an unhealthy gut microbiome, all linked to ...

Emerging evidence suggests that gut biotics may help reduce inflammation and improve psoriasis severity, but larger studies ...

Artelo Biosciences, Inc. (Nasdaq: ARTL) (“Artelo” or the “Company”), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with ...

Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signalling pathways to develop treatments for people living with cancer, pain, dermatologic ...

Researchers tested plant-derived prebiotic candidates against selected skin-associated bacteria and found that garlic, ...

Biodexa Pharmaceuticals PLC (Nasdaq: BDRX) (“Biodexa” or “the Company”), a clinical stage biopharmaceutical company developing innovative products focused on the treatment or prevention of ...

U.S. News & World Report has again ranked The Chinese University of Hong Kong (CUHK)'s Faculty of Medicine (CU Medicine) No. 2 globally in Gastroenterology & Hepatology, maintaining a top-three ...

Vascular dementia (VaD) is the second most common form of dementia globally, yet it remains significantly underserved by disease-modifying therapeutics.

Anxiety and depression disorders are pervasive mental health issues that affect millions globally, transcending age and ...